GM and Lockheed Martin Partner to Strengthen U.S. Defense Manufacturing Capacity 
Hyundai to Acquire SoftBank’s Remaining Boston Dynamics Stake for $325 Million 
SoftBank Shares Drop as OpenAI Losses and Rising Costs Spark Investor Concerns 
Kingboard Holdings Shares Surge After HK$11.77 Billion Block Trade to Expand PCB and AI Supply Chain Business 
Meta Seeks Legal Shield From Child-Harm Lawsuits Amid KOSA Talks 
Trump Administration Delays DeepSeek and CXMT Trade Blacklist Designations Amid U.S.-China Tensions 
Microsoft Taps AWS to Support GitHub Amid AI Coding Boom 
Google Gemini Co-Lead Noam Shazeer Leaves for OpenAI Amid AI Talent Race 
Qantas Nears Launch of World’s Longest Non-Stop Flights to London and New York 
Qantas Unveils Wellness-Focused Nonstop Sydney-London Flights to Reduce Jet Lag 
SpaceX Stock Slides After IPO Rally as Valuation Concerns Grow 
Frank Stronach Found Guilty of Sexual Assault and Indecent Assault in Ontario Court 
G7 Explores AI Access Deal With U.S. Amid Anthropic Restrictions 
SpaceX Surpasses Amazon in Market Value as Post-IPO Rally Accelerates 
Obayashi to Acquire Multiplex in $526M Expansion Deal 
Apple Signals Product Price Hikes Amid Rising Memory Chip Costs 
Jio IPO Filing Nears as Reliance Targets $4 Billion Market Debut 
NEW YORK, Nov. 30, 2015 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of Texas on behalf of investors who purchased Nobilis Health Corp. (NYSE:HLTH) securities between April 2, 2015 and October 8, 2015.
Click here to learn about the case: http://docs.wongesq.com/HLTH-Info-Request-Form-951. There is no cost or obligation to you.
The complaint alleges that defendants failed to disclose during the Class Period that the Company’s claimed success rates for its AccuraScope procedure lacked recognition from any university, medical body, or insurance company, that the Company overstated its 2014 revenues by as much as $36 million, and that, as a result of the aforementioned, the Company’s 2014 revenue growth rate was actually 44% as opposed to the 161% represented by the Company.
On October 9, 2015, Seeking Alpha published a report on Nobilis asserting, among other things: accounting red flags, questionable marketing practices and substantial insider sales. Shares have fallen from a closing price of $5.24 per share on October 8, 2015, to a close of just $3.06 per share on October 28, 2015.
If you suffered a loss in Nobilis Health you have until December 21, 2015 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://docs.wongesq.com/HLTH-Info-Request-Form-951.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: [email protected]
